Aardvark Therapeutics NASDAQ: AARD
7 press releases in the last 30 days — tracked in real time across the global wires PPN World aggregates.
7
last 30 days
7
recent window
5
wires
Aug 17, 2026
latest
Activity — 12 weeks
Finance🇺🇸 United States
Latest releases
- AARD Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Aardvark Therapeutics, Inc.PR Newswire (Canada) — Energy · Aug 17, 2026
- AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud LawsuitPR Newswire (US) — Technology · Aug 17, 2026
- Kaplan Fox Alerts Aardvark Therapeutics, Inc. (AARD) Investors to a Securities Class Action Deadline on October 13, 2026Newsfile Corp (Canada) — All Releases · Aug 17, 2026
- AARD INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Aardvark Therapeutics, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the FirmGlobeNewswire — Private Companies · Aug 17, 2026
- Pomerantz LLP Announces The Filing of a Class Action Against Aardvark ...PR-Inside · Aug 17, 2026
2 more Aardvark Therapeutics releases — subscribers only
Full history, real-time feed, instant email alerts and AI summaries — 72-hour free trial.
Unlock full accessWires carrying it
Aardvark Therapeutics's comms team?
Distribute your next release to the global wires with PPN Source — and watch its pickup right here.
PPN Source →Follow Aardvark Therapeutics in real time.
Watchlist, instant alerts and the full dossier across 1400+ feeds — 72-hour free trial, no card required.